Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China.
Frequently asked questions
What sector does Autek China Inc (300595) operate in?
Autek China Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Autek China Inc (300595) current stock price?
As of the latest data, Autek China Inc stock price is CN¥11.75, with a previous close of CN¥11.70. Autek China Inc gained CN¥0.05 in the last trading session, representing a 0.43% increase.
What is Autek China Inc (300595) current market capitalization?
Autek China Inc market cap is approximately 10.52 billion.
What is Autek China Inc (300595) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.52, and the forward EPS is CN¥0.57.
What is Autek China Inc (300595) Price-to-Earnings (P/E) ratio?
Autek China Inc current P/E ratio is 22.6, with a forward P/E of 20.45.
Does Autek China Inc (300595) pay dividends?
Yes. Autek China Inc pays semiannual dividends with an annualized yield of 2.25% and an estimated annual payout of CN¥0.26 per share.
When is the next ex-dividend date for Autek China Inc (300595)?
The next ex-dividend date is scheduled for November 20, 2026.
What is Autek China Inc (300595) beta (volatility) score?
Autek China Inc has a beta of 0.568, indicating lower volatility than the overall market.
